✦ LIBER ✦

Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation

✍ Scribed by Rapanotti, M C; Arcese, W; Buffolino, S; Iori, A P; Mengarelli, A; De Cuia, M R; Cardillo, A; Cimino, G

Book ID: 110010061
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 150 KB
Volume: 19
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1700723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive immunotherapy for relapse of ch

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

✍ van Rhee, F; Savage, D; Blackwell, J; Orchard, K; Dazzi, F; Lin, F; Chase, A; Bu 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 64 KB

Salvage chemotherapy with donor lymphocy

Salvage chemotherapy with donor lymphocyte infusion and STI 571 in a patient relapsing with B-lymphoblastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation

✍ László Gopcsa; Anikó Barta; Anikó Bányai; János Dolgos; Gabriella Halm; Katalin 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 438 KB

Non-random involvement of chromosome 13

Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia

✍ Andrew Chase; Julie Pickard; Richard Szydlo; Stephanie Coulthard; John M. Goldma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Chronic myeloid leukemia (CML) patients with persistent or relapsed disease following bone-marrow transplantation (BMT) usually show both clonal and non-clonal cytogenetic changes in addition to the Philadelphia (Ph) translocation. These changes are presumably due to conditioning prior to transplant

Successful donor leukocyte transfusion a

Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay

✍ Ogawa, H; Tsuboi, A; Oji, Y; Tamaki, H; Soma, T; Inoue, K; Sugiyama, H 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB